Invictus’ Acreage Pharms to Become a Registered Cannabis Supplier in Saskatchewan

INVICTUS MD STRATEGIES CORP. GENE:CA IVITF is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority (“SLGA”) once legislation is implemented on October 17, 2018. In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17.

“We are thrilled to become a registered supplier in Saskatchewan, our third provincial agreement behind British Columbia and Alberta,” said Dan Kriznic CEO and Chairman for Invictus. “We can feel the momentum building ahead of legalization on October 17, 2018 and are actively seeking agreements with additional provinces to help ensure governments across Canada have enough supply to meet consumer demand.”

Invictus is set to gain access to the retail market in Saskatchewan through an LOI with GTEC Holdings Ltd. (“GTEC”) (TSXV: GTEC) that provides the Company with an opportunity to fill purchase orders that GTEC is seeking from third party licensed producers for the purposes of supporting GTECs distribution channels.

Invictus’ product portfolio includes 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Each brand has been crafted for a specific target audience and his or her lifestyle.

In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.